-
1
-
-
70349969112
-
Eslicarbazepine acetate
-
Shorvon S, Perucca E, Engel J, editors 3rd ed. Oxford: Blackwell Publishing
-
Almeida L, Bialer M, Soares-da-Silva P. Eslicarbazepine acetate. In: Shorvon S, Perucca E, Engel J, editors. The treatment of epilepsy. 3rd ed. Oxford: Blackwell Publishing, 2009: 485-98
-
(2009)
The Treatment of Epilepsy
, pp. 485-98
-
-
Almeida, L.1
Bialer, M.2
Soares-Da-Silva, P.3
-
2
-
-
43049177758
-
Pharmacokinetics of eslicarbazepine acetate in patients with moderate hepatic impairment
-
Mar
-
Almeida L, Potgieter JH, Maia J, et al. Pharmacokinetics of eslicarbazepine acetate in patients with moderate hepatic impairment. Eur J Clin Pharmacol 2008 Mar; 64 (3): 267-73
-
(2008)
Eur J Clin Pharmacol
, vol.64
, Issue.3
, pp. 267-73
-
-
Almeida, L.1
Potgieter, J.H.2
Maia, J.3
-
3
-
-
44249105976
-
Effect of renal impairment on the pharmacokinetics of eslicarbazepine acetate
-
Maia J, Almeida L, Falcão A, et al. Effect of renal impairment on the pharmacokinetics of eslicarbazepine acetate. Int J Clin Pharmacol Ther 2008 Mar; 46 (3): 119-30 (Pubitemid 351721154)
-
(2008)
International Journal of Clinical Pharmacology and Therapeutics
, vol.46
, Issue.3
, pp. 119-130
-
-
Maia, J.1
Almeida, L.2
Falcao, A.3
Soares, E.4
Mota, F.5
Potgieter, M.A.6
Potgieter, J.H.7
Soares-da-Silva, P.8
-
4
-
-
33847611166
-
Eslicarbazepine acetate: A double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures
-
DOI 10.1111/j.1528-1167.2007.00984.x
-
Elger C, Bialer M, Cramer JA, et al. Eslicarbazepine acetate: a double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures. Epilepsia 2007 Mar; 48 (3): 497-504 (Pubitemid 46365199)
-
(2007)
Epilepsia
, vol.48
, Issue.3
, pp. 497-504
-
-
Elger, C.1
Bialer, M.2
Cramer, J.A.3
Maia, J.4
Almeida, L.5
Soares-Da-Silva, P.6
-
5
-
-
61849168486
-
Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: A randomized, double-blind, placebo-controlled, parallel-group phase III study
-
Mar
-
Elger C, Halasz P, Maia J, et al. Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study. Epilepsia 2009 Mar; 50 (3): 454-63
-
(2009)
Epilepsia
, vol.50
, Issue.3
, pp. 454-63
-
-
Elger, C.1
Halasz, P.2
Maia, J.3
-
6
-
-
77951297857
-
Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy
-
Mar 16
-
Ben-Menachem E, Gabbai AA, Hufnagel A, et al. Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy. Epilepsy Res 2010 Mar 16; 89 (2-3): 278-85
-
(2010)
Epilepsy Res
, vol.89
, Issue.2-3
, pp. 278-85
-
-
Ben-Menachem, E.1
Gabbai, A.A.2
Hufnagel, A.3
-
7
-
-
70349972675
-
Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures
-
Nov
-
Gil-Nagel A, Lopes-Lima J, Almeida L, et al. Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures. Acta Neurol Scand 2009 Nov; 120 (5): 281-7
-
(2009)
Acta Neurol Scand
, vol.120
, Issue.5
, pp. 281-7
-
-
Gil-Nagel, A.1
Lopes-Lima, J.2
Almeida, L.3
-
8
-
-
78649248897
-
Long-term efficacy and safety of eslicarbazepine acetate: Results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy
-
Oct
-
Halasz P, Cramer JA, Hodoba D, et al. Long-term efficacy and safety of eslicarbazepine acetate: results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy. Epilepsia 2010 Oct; 51 (10): 1963-9
-
(2010)
Epilepsia
, vol.51
, Issue.10
, pp. 1963-9
-
-
Halasz, P.1
Cramer, J.A.2
Hodoba, D.3
-
11
-
-
0016916438
-
Prediction of creatinine clearance from serum creatinine
-
Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16 (1): 31-41
-
(1976)
Nephron
, vol.16
, Issue.1
, pp. 31-41
-
-
Cockcroft, D.W.1
Gault, M.H.2
-
12
-
-
0141516469
-
Oxcarbazepine: Chemistry, biotransformation and pharmacokinetics
-
Levy RH, Mattson R, Meldrum BS, et al., editors 5th ed Philadelphia (PA):Lippincott
-
Bialer M. Oxcarbazepine: chemistry, biotransformation and pharmacokinetics. In: Levy RH, Mattson R, Meldrum BS, et al., editors. Antiepileptic drugs. 5th ed. Philadelphia (PA): Lippincott, 2002: 459-65
-
(2002)
Antiepileptic Drugs
, pp. 459-65
-
-
Bialer, M.1
-
13
-
-
79956136111
-
Pharmacokinetics of the monohydroxy derivative of oxcarbazepine and its enantiomers after a single intravenous dose given as racemate compared with a single oral dose of oxcarbazepine
-
Jun
-
Flesch G, Czendlik C, Renard D, et al. Pharmacokinetics of the monohydroxy derivative of oxcarbazepine and its enantiomers after a single intravenous dose given as racemate compared with a single oral dose of oxcarbazepine. Drug Metab Dispos 2011 Jun; 39 (6): 1103-10
-
(2011)
Drug Metab Dispos
, vol.39
, Issue.6
, pp. 1103-10
-
-
Flesch, G.1
Czendlik, C.2
Renard, D.3
-
14
-
-
77749279921
-
Pharmacokinetic interaction study between eslicarbazepine acetate and lamotrigine in healthy subjects
-
Apr
-
Almeida L, Nunes T, Sicard E, et al. Pharmacokinetic interaction study between eslicarbazepine acetate and lamotrigine in healthy subjects. Acta Neurol Scand 2010 Apr; 121 (4): 257-64
-
(2010)
Acta Neurol Scand
, vol.121
, Issue.4
, pp. 257-64
-
-
Almeida, L.1
Nunes, T.2
Sicard, E.3
-
15
-
-
77952477242
-
Pharmacokinetic interaction study between eslicarbazepine acetate and topiramate in healthy subjects
-
Jun
-
Nunes T, Sicard E, Almeida L, et al. Pharmacokinetic interaction study between eslicarbazepine acetate and topiramate in healthy subjects. Curr Med Res Opin 2010 Jun; 26 (6): 1355-62
-
(2010)
Curr Med Res Opin
, vol.26
, Issue.6
, pp. 1355-62
-
-
Nunes, T.1
Sicard, E.2
Almeida, L.3
|